Experimental data obtained from transgenic mouse models characterized by muscle-specific overexpression of IGF-1 suggested mIGF-1 as therapeutic agents in human muscular dystrophies (Fiorotto et al. 2003; Musarò et al. 2004; Shavlakadze et al. 2004). This evidence concerns the gene IGF1 and muscular dystrophy.